We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Actions that trial sponsors should consider to build resilience into clinical trial design
Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions.
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
Guidance for healthcare and public health commissioners on planning treatment services for dependence on prescription and over-the-counter medicines.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Paper prepared by Imperial College on timing & local triggering of non-pharmaceutical interventions.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
Paper by the Imperial College COVID-19 Response Team.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
How to use a micro-randomised trial to evaluate your digital health product.
Paper prepared by Imperial College on the impact of non-pharmaceutical interventions.
How investigators and sponsors should manage clinical trials during COVID-19
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.